(ALAMA) AMA - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: GB00BNKGZC51
ALAMA EPS (Earnings per Share)
ALAMA Revenue
ALAMA: Remote Assistance, Video Conferencing, Augmented Reality, Online
AMA Corporation Plc is a global player in the development of remote assistance and videoconference solutions, operating in multiple countries across Europe, North America, and Asia. The companys XpertEye suite is a comprehensive solution that incorporates augmented reality, workflow management, and online scheduling, making it a valuable tool for industries that require remote expertise and collaboration. With a range of products, including XE aR, XE aR+, XpertEye Proceed, and XpertEye Schedule, AMA Corporation Plc caters to diverse needs, from simple remote assistance to complex project management. The companys solutions are compatible with various devices, including smartphones, smart glasses, and specialized equipment like microscopes and endoscopes.
As a Health Care Technology company, AMA Corporation Plc is well-positioned to capitalize on the growing demand for telemedicine and remote healthcare services. The companys expertise in augmented reality and remote assistance can be applied to various medical fields, such as training, diagnostics, and treatment. With its global presence and diverse product offerings, AMA Corporation Plc has the potential to expand its customer base and increase revenue. The companys commitment to providing project management, training, maintenance, and technical support services also enhances its value proposition.
Analyzing the
Using both
Additional Sources for ALAMA Stock
ALAMA Stock Overview
Market Cap in USD | 15m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
ALAMA Stock Ratings
Growth Rating | -56.5 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 43.6 |
Analysts | - |
Fair Price Momentum | 0.18 EUR |
Fair Price DCF | - |
ALAMA Dividends
Currently no dividends paidALAMA Growth Ratios
Growth Correlation 3m | 62.8% |
Growth Correlation 12m | 35.8% |
Growth Correlation 5y | -87.1% |
CAGR 5y | -54.92% |
CAGR/Max DD 5y | -0.56 |
Sharpe Ratio 12m | -0.03 |
Alpha | 16.61 |
Beta | 0.684 |
Volatility | 118.68% |
Current Volume | 28.7k |
Average Volume 20d | 19.7k |
As of June 25, 2025, the stock is trading at EUR 0.26 with a total of 28,694 shares traded.
Over the past week, the price has changed by +7.92%, over one month by +23.33%, over three months by +12.12% and over the past year by +32.82%.
No, based on ValueRay´s Analyses, AMA (PA:ALAMA) is currently (June 2025) a stock to sell. It has a ValueRay Growth Rating of -56.47 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALAMA is around 0.18 EUR . This means that ALAMA is currently overvalued and has a potential downside of -30.77%.
AMA has no consensus analysts rating.
According to our own proprietary Forecast Model, ALAMA AMA will be worth about 0.2 in June 2026. The stock is currently trading at 0.26. This means that the stock has a potential downside of -23.08%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 0.1 | -61.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 0.2 | -23.1% |